Key Indicators On Trade Set Up In General 1. Push Set Up 2. Range Set up 3. Break & Retest Set Up Notes On Session # WM Technology Inc. Stock Quote - Double Formation * 4 Retracements & Numbered | Completed Survey * 0.60 USD | Area Of Value | Subdivision 1 - Triple Formation * 012345 | Wave Count | Uptrend Bias | Subdivision 2 * Retracement Not Numbered | ((50))% | Subdivision 3 * Daily Time Frame | Entry Settings Condition Active Sessions On Relevant Range & Elemented Probabilities; European Session(Upwards) - US-Session(Downwards) - Asian Session(Ranging) Conclusion | Trade Plan Execution & Risk Management On Demand; Overall Consensus | Buy
US stock index futures were firmer in early trade this morning. They were firmer in early trade yesterday morning too. But that didn’t stop them turning lower as the session progressed. Yesterday’s move saw the S&P 500 hit lows last seen on Friday, 20th December when investors were dumping stocks following the Fed’s ‘hawkish rate cut’ from the previous Wednesday. It was a similar story for all the US majors yesterday, and, to show that the sell-off was tech-led, the NASDAQ 100 fell back to levels last seen at the end of November. The lows were hit early evening European time. After that, the US indices recovered somewhat, ending the day with modest losses, although, as yesterday, the mid-cap Russell 2000 managed to creep into positive territory. Does this week’s stock market behaviour provide clues for the rest of the year? Probably not. It’s fair to say that much of the recent volatility and downside pressure comes as a result of year-end window dressing and fund rebalancing, as managers shift their weightings between equities and bonds. This became necessary due to weakness in the bond market since mid-September (ironically just after the Fed slashed rates by 50 basis points) contrasting with strength across equities going back to October 2023. So we’ll have to see how things go for the rest of this month, particularly once we get past Trump’s inauguration on 20th January. At the time of writing (just after the European close again) US stock indices are staging an impressive rally and on their highs. It’s probably too late for the S&P to complete a full ‘Santa Rally’, as that would require an upward move of over 150 points today. The yield on the 10-year is back up to 4.58% this afternoon, although equity buyers don’t seem too concerned. While elevated yields may indicate expectations of stronger economic growth, rather than simply an inflation bounce, they’re also a response to the US’s budget deficit, and the prospect of the huge Treasury issuance required to cover it.
Volume has returned, Yeeees Bois. What more needs saying, but clearly TradingView thinks otherwise. Turns out minimum wordcount in descriptions are a thing. Sorry for wasting your time .
The Market Anomaly Detector (MAD) Indicator demonstrates effective performance in identifying market entry and exit opportunities. Here’s a summary of its performance: Key Observations: 1. Accurate Buy/Sell Signals: • The indicator marks precise Buy signals (green labels) during upward trends. • Sell signals (red labels) appear accurately in declining market phases, providing timely insights for traders. 2. Trend Identification: • The background shading highlights market conditions: • Green background: Indicates bullish market momentum. • Red background: Highlights bearish market trends. 3. Dynamic Price Movement Tracking: • The Bollinger Bands and moving averages overlay align with the signals, reinforcing their reliability. • Reversal signals near the bands capture price rejections effectively. 4. Risk-Reward Ratio: • The chart showcases areas where significant profits could have been achieved, particularly during sustained trends following the signals. 5. Filter for False Signals: • The cooldown mechanism reduces noise by avoiding over-frequent signals in sideways market conditions. 6. The True Mean (blue line) is a critical component that enhances trading accuracy by acting as a dynamic guide for trend direction, support, and resistance. Here’s how it performs: Dynamic Support and Resistance: • Support: • When the price pulls back toward the True Mean in a bullish trend, it often finds support. • In the chart, areas where the price tests the True Mean and then moves upward confirm the line’s ability to identify buying opportunities. • Resistance: • In bearish conditions, the price tests the True Mean from below but fails to break above it, signaling a continuation of the downtrend. • This is useful for identifying short entries. Performance Highlights: • During a bullish breakout (highlighted on the right), the MAD indicator identified the entry early, allowing traders to capitalize on the upward momentum. • Several short trades during bearish conditions also align closely with trend reversals, helping traders manage risks efficiently. Overall, the MAD Indicator provides actionable insights, balancing signal frequency and accuracy, and is well-suited for traders seeking to capture trends and reversals effectively.
Make a Long position for GOLD JUST NOW! Target is 2648 tonight ! Ba aware and relax !
Looks like a big cup & handle but not accurate. The stock gave a long consolidation breakout, and volumes are also shooting up.
I spend time researching and finding the best entries and setups, so make sure to boost and follow for more. Phathom Pharmaceuticals ( NASDAQ:PHAT ): High-Growth Potential in Biopharmaceuticals Trade Setup: - Entry Price: $7.53 (Activated) - Stop-Loss: $5.67 - Take-Profit Targets: - TP1: $22.00 - TP2: $41.80 Company Overview: Phathom Pharmaceuticals ( NASDAQ:PHAT ) is a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases. With a pipeline of promising drugs, NASDAQ:PHAT is gaining attention as a high-potential player in its sector. Recent FDA approvals and upcoming clinical trial data releases have positioned the company for significant upside. These developments could catalyze rapid stock price appreciation in the coming months. Earnings Reports: - In its most recent quarter, NASDAQ:PHAT reported revenues of $12.3 million, driven by early sales from its newly approved drug for acid-related conditions. - Operating losses narrowed compared to previous quarters, reflecting disciplined cost management. Valuation Metrics: - Market Cap: $500 million, indicating a small-cap stock with room for growth. - Price-to-Sales (P/S) Ratio: 4.1, suggesting moderate undervaluation compared to industry averages. Market News: - Phathom recently announced successful Phase III trial results for another key drug in its pipeline, expected to drive future revenue growth. - The company is expanding its distribution partnerships, aiming to broaden its market reach. Technical Analysis (Daily Timeframe): - Current Price: $7.53 - Moving Averages: - 50-Day SMA: $6.80 - 200-Day SMA: $7.00 - Relative Strength Index (RSI): Currently at 55, signalling neutral momentum with room for further upside. - Support and Resistance Levels: - Immediate Support: $7.00 - Resistance: $9.00 The stock has activated the entry at $7.53, with strong support at $7.00. A breakout above $9.00 could set the stage for rapid movement toward TP1 at $22.00 and TP2 at $41.80. Risk Management: The stop-loss at $5.67 limits downside risk to approximately 25%, while the first take-profit target at $22.00 offers a **192% gain**, and TP2 provides a massive **455% return**, making this an attractive trade for long-term investors. Key Takeaways: - NASDAQ:PHAT is a high-risk, high-reward opportunity in the biotech sector, driven by a strong pipeline and recent FDA approvals. - The trade setup offers an excellent risk-to-reward ratio, aligning with the stock’s growth potential. - Ideal for investors seeking exposure to a rapidly developing biopharmaceutical company. When the Market’s Call, We Stand Tall. Bull or Bear, We’ll Brave It All!
major reversal weekly candle as previously expected, should this candle close anywhere above 927, expect sustained upside move in the price of platinum to at least 1040 and a major target of 1300 high probability trade: buy the retracement between 910 and 922 after the weekly close above 927, with Stop weekly close below 890
Buying the BND ETF (Vanguard Total Bond Market ETF) can be a smart move for several reasons, especially for those looking to diversify their portfolio, generate income, or manage risk. Here are some compelling reasons why you might consider buying BND: 1. Diversification Broad Exposure to the Bond Market: BND gives you access to a wide variety of U.S. investment-grade bonds, including government, corporate, and mortgage-backed securities. This diversification reduces the risk compared to holding individual bonds or concentrating on a single sector of the bond market. 2. Income Generation Regular Interest Payments: BND invests in bonds that pay interest, providing a consistent stream of income. If you're a retiree or someone looking for reliable income without the volatility of stocks, BND can be a good choice. 3. Lower Risk Less Volatile Than Stocks: Bonds are generally less volatile than stocks, which makes BND a safer option for risk-averse investors. It tends to fluctuate less and is less affected by market swings. Stability: Since BND tracks a broad basket of U.S. bonds, it provides stability during times of stock market turbulence. It can serve as a defensive asset in your portfolio, offering protection during market downturns. 4. Cost-Effective Low Expense Ratio: With an expense ratio of just 0.035%, BND is extremely affordable. Compared to actively managed funds or other bond ETFs, it offers exposure to the bond market at a fraction of the cost. 5. Liquidity Easily Tradable: As an ETF, BND can be bought and sold like a stock, meaning you have liquidity and can enter or exit the investment at any time during market hours. This makes it more flexible than holding individual bonds, which may be harder to sell quickly. 6. Accessibility for Small Investors Low Minimum Investment: Unlike individual bonds, which may require large sums to purchase, you can buy BND in increments of a single share, making it accessible for investors with smaller portfolios. 7. Hedge Against Stock Market Volatility Diversification in Times of Market Stress: When the stock market experiences significant volatility or downturns, bond prices often move in the opposite direction, helping balance out the performance of your overall portfolio. BND is a good way to hedge against market volatility. 8. Intermediate Duration for Balanced Risk Moderate Duration Exposure: BND focuses on bonds with intermediate durations, balancing the risk between short-term and long-term bonds. This makes it less sensitive to interest rate changes compared to long-duration bonds, while still providing the benefits of bond exposure. 9. Performance During Economic Uncertainty Defensive Nature: Bonds are generally seen as safer during economic uncertainty. While the stock market can be volatile during recessions or periods of high inflation, bonds tend to provide more stability and reliable returns. 10. Tax Efficiency More Tax-Efficient Than Actively Managed Funds: Since BND is passively managed, it tends to have fewer capital gains distributions, which can be more tax-efficient than actively managed bond funds.
Good volume pushing price upwards, if the weekly candle closes above 920 today, i expect price has bottomed and must target 1600$